> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-240/
- Published: 2019-09-29T12:00:00.000Z
- Updated: 2026-09-15T01:53:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145128

[**Guide on Device Software Policy Changes**](https://www.fdaweb.com/guide-on-device-software-policy-changes/)  
*Federal Register* notice: FDA makes available a final guidance on “Changes to Existing Medical Software Policies Resulting From Section 3060 of the 21st Century Cures Act.” 09/27/2019  

[**Guide on Type A Medicated Articles**](https://www.fdaweb.com/guide-on-type-a-medicated-articles/)  
*Federal Register* notice: FDA makes available a draft guide on demonstrating bioequivalence for soluble powder oral dosage form products and Type A medicated articles made from soluble APIs. 09/27/2019  

[**Clinical Decision Support Software Guide**](https://www.fdaweb.com/clinical-decision-support-software-guide/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Clinical Decision Support Software.” 09/27/2019  

[**Draft Guide on Device e-Submissions**](https://www.fdaweb.com/draft-guide-on-device-e-submissions/)  
*Federal Register* notice: FDA makes available a draft guidance on medical device regulatory electronic submissions. 09/26/2019  

[**Atropine Sulfate Not Withdraw Over Safety/Efficacy**](https://www.fdaweb.com/atropine-sulfate-not-withdraw-over-safety-efficacy/)  
*Federal Register* notice: FDA determines that Hospira’s atropine sulfate ansyr plastic syringe was not withdrawn due to safety or effectiveness reasons. 09/25/2019  

[**Regulatory Review Period for Med–El EAS Hearing Device**](https://www.fdaweb.com/regulatory-review-period-for-med-el-eas-hearing-device/)  
*Federal Register* notice: FDA determines for patent extension purposes the regulatory review period for Med-El Electromedizinische Gerate’s medical device Med–El EAS, intended to provide electrical stimulation for patients with low-frequency hearing sensitivity. 09/25/2019  

[**Info Collection Extension on Transplant Tissues**](https://www.fdaweb.com/info-collection-extension-on-transplant-tissues/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Human Tissue Intended for Transplantation — 21 CFR Part 1270.” 09/25/2019  

[**Draft Guide on Patient Input on Device Trials**](https://www.fdaweb.com/draft-guide-on-patient-input-on-device-trials/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Patient Engagement in the Design and Conduct of Medical Device Clinical Investigations.” 09/24/2019